Biotage intends to initiate negotiations regarding an acquisition of Chreto ApS following a resolution not to exercise existing call option
Stockholm – Biotage AB (publ) (Biotage), (Nasdaq Stockholm: BIOT.ST) has today resolved to initiate negotiations to acquire the Danish company Chreto ApS (“Chreto”) following a decision not to exercise the current call option to acquire all outstanding shares in Chreto. On August 31, 2016, Biotage published that Biotage had invested 15 MDKK (corresponding to approx. 20.7 MSEK[1]) by subscription of new shares in Chreto. At the same time Biotage was granted an option that gave the right but not the obligation to acquire all outstanding shares in Chreto during the period up and until